PSB 603 - Bogus
Discontinued ProductUnfortunately PSB 603 - Bogus (Cat. No. 2683) has been withdrawn from sale for commercial reasons.
Adenosine A2B receptor antagonist that displays > 17000-fold selectivity over other adenosine receptors (Ki values are 0.568, > 10000, > 10000 and > 10000 nM for A2B, A1, A2A and A3 receptors respectively).
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 529.01. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.89 mL||9.45 mL||18.9 mL|
|5 mM||0.38 mL||1.89 mL||3.78 mL|
|10 mM||0.19 mL||0.95 mL||1.89 mL|
|50 mM||0.04 mL||0.19 mL||0.38 mL|
References are publications that support the products' biological activity.
View Related Products by Product Action
Keywords: PSB 603, supplier, A2B, adenosine, Adenosine, A2B, Receptors, Adenosine, A2B, Receptors, Tocris Bioscience
Citations for PSB 603 - Bogus
Citations are publications that use Tocris products.
Currently there are no citations for PSB 603 - Bogus.
Reviews for PSB 603 - Bogus
There are currently no reviews for this product. Be the first to review PSB 603 - Bogus and earn rewards!
Have you used PSB 603 - Bogus?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.